Accepted
at 1:41 p.m. Jul, 09, 2024
by
IantheBFG
Author:
mohannadkh10
Type of change:
Updated content
Rationale for change
Uworld "early treatment with fibrinolytics, namely recombinant forms of tissue plasminogen activator (eg, tenecteplase, alteplase), improves clinical outcomes"
Source: UWorld - Step 1 823
Before
After
Extra
Extra
Extra
Extra
Text
What class of drugs may be used for reperfusion therapy for STEMI when PCI is not available?
{{c1::Thrombolytics}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy



Watch Thrombolytics



Watch Thrombolytics
Sketchy 2






Sketchy Extra
Empty field
Picmonic
Empty field
Physeo


Bootcamp
Watch associated Bootcamp video - Coagulation and Fibrinolysis: Fibrinolysis and Inhibitors of Hemostasis
Watch associated Bootcamp video - Myocardial Infarction: Management
Watch associated Bootcamp video - Myocardial Infarction: Management
OME
Empty field
Additional Resources
One by one
Empty field


